Clinical Trials

186 enrolled

Advanced Solid Tumor

NCT04278287 2024-12-13

Chemoradiotherapy in Unresectable Esophageal Cancer

105 enrolled

Esophageal Neoplasms

NCT05501665 2024-10-17

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

25 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02024009 2024-07-25

SCALOP-2

159 enrolled

Pancreatic Neoplasms

NCT05832892 2024-06-14

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

Phase 1/2 Unknown

41 enrolled

Pancreatic Neoplasms

NCT05693844 2024-05-10

Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors

15 enrolled

Advanced or Metastatic Solid Tumors

NCT05681650 2023-12-12

HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors

30 enrolled

HER2 Positive Advanced Solid Tumors

NCT03649321 2023-11-09

Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer

9 enrolled 12 charts

Pancreatic Neoplasms

NCT02178436 2023-11-07

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

15 enrolled 13 charts

Pancreatic Neoplasms

NCT00934895 2023-09-18

Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca

27 enrolled 12 charts

Breast Neoplasms

NCT02382406 2023-05-23

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

46 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT02620865 2023-05-15

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

2 enrolled 9 charts

Pancreatic Neoplasms

NCT05251038 2023-05-11

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

Phase 1/2 Withdrawn

Pancreatic Neoplasms

NCT05699811 2023-04-28

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

40 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT03112590 2023-04-19

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

51 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT04826016 2023-03-20

POLTER

Phase 1/2 Withdrawn

Advanced Breast Cancer

NCT03524898 2022-09-28

NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma

39 enrolled

Sarcoma

Neoplasms, Sarcoma

NCT02379247 2022-06-07

BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer

43 enrolled 18 charts

Breast Neoplasms

NCT02562898 2021-05-06

Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

18 enrolled 15 charts

Metastatic Pancreatic Adenocarcinoma

NCT02733250 2021-02-16

URCOH-PMS-001

10 enrolled

Lung Neoplasms

NCT00442260 2021-01-22

Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer

2 enrolled 1 chart

Breast Neoplasms

NCT00851877 2020-08-21

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

37 enrolled 9 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT01431794 2020-01-22

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

23 enrolled 10 charts

Carcinoma, Pancreatic Diseases

NCT03994107 2020-01-22

Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer

Phase 1/2 Unknown

40 enrolled

Breast Neoplasms

NCT02358161 2020-01-09

MATRIX

78 enrolled

Pancreatic Neoplasms

NCT04148885 2019-11-04

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

Phase 1/2 Unknown

44 enrolled

Genitourinary

Castration-resistant Prostate Cancer

NCT01893801 2019-05-29

Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA

25 enrolled 17 charts

Pancreatic Neoplasms

NCT02075021 2018-10-15

rev/abraxane

3 enrolled 3 charts

Plasma cell

Multiple Myeloma, Recurrence

NCT02331251 2018-07-02

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

BreastGastrointestinalSarcomaThoracic

81 enrolled

Breast Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT00470548 2018-01-10

Abraxane and Alimta in Advanced Solid Tumors

49 enrolled 10 charts

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Breast Neoplasms, Male

NCT00570674 2017-11-13

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

29 enrolled 13 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Adenosquamous

NCT01730222 2017-09-01

PACT-19

137 enrolled

Disease, Pancreatic Neoplasms

NCT00748553 2017-07-26

VA

30 enrolled 7 charts

Breast Neoplasms

NCT02273713 2017-05-31

ACTION

154 enrolled

Esophageal Neoplasms, Neoplasm Metastasis

NCT01488552 2016-08-18

Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

60 enrolled

Pancreatic Neoplasms

NCT01693276 2015-10-26

Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

3 enrolled

Pancreatic Neoplasms

NCT00544648 2014-06-09

Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC

13 enrolled 15 charts